Bo Ye
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Medicine top 10%
Papers in
-
- Pericarditis and Cardiac Tamponade 7
Bo Ye
80 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 120
- Cancer Research 169
- Molecular Medicine 53
- Molecular Biology 672
- Cardiology and Cardiovascular Medicine 214
- Oncology 253
Countries citing papers authored by Bo Ye
This map shows the geographic impact of Bo Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Ye more than expected).
Fields of papers citing papers by Bo Ye
This network shows the impact of papers produced by Bo Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Ye. The network helps show where Bo Ye may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bo Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 11 | |
| 5 | 2023 | 55 | |
| 6 | 2021 | 1 | |
| 7 | 2020 | 38 | |
| 8 | miR-424-5p Promotes Proliferation, Migration and Invasion of Laryngeal Squamous Cell Carcinoma | 2019 | 3 |
| 9 | 2019 | 38 | |
| 10 | 2019 | 22 | |
| 11 | 2019 | 10 | |
| 12 | 2016 | 31 | |
| 13 | 2015 | 29 | |
| 14 | Abstract 13278: {beta}-Catenin Inhibition of NaV1.5 Requires both TCF4 and FoxO1 in Cardiomyocytes | 2013 | 1 |
| 15 | 2013 | 34 | |
| 16 | 2012 | 21 | |
| 17 | 2009 | 41 | |
| 18 | An offset cancellation CMOS VGA for GPS receiver | 2009 | 0 |
| 19 | 2009 | 9 | |
| 20 | 2007 | 24 |
About Bo Ye
Bo Ye is a scholar working on Cardiology and Cardiovascular Medicine, Transplantation, Cancer Research, Oncology and Molecular Biology, having authored 90 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pericarditis and Cardiac Tamponade (7 papers), Wnt/β-catenin signaling in development and cancer (7 papers), Cancer-related gene regulation (6 papers), MicroRNA in disease regulation (5 papers), Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Research Studies (5 papers), Ubiquitin and proteasome pathways (4 papers) and Myasthenia Gravis and Thymoma (4 papers). The work is most often cited by research in Cancer Research (169 citations), Molecular Medicine (53 citations), Molecular Biology (672 citations), Cardiology and Cardiovascular Medicine (214 citations) and Oncology (253 citations). Bo Ye has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Faqian Li, Haodong Xu, Ning Hou, Fangming Zhong, Guocan Yu, Xuejun Wang, Xudong Xu, Haodong Xu, Hong Shen and Jian Wu. Their work appears in journals such as PLoS ONE, Journal of Molecular and Cellular Cardiology, Circulation Heart Failure, Medical Oncology and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.